Potential Alzheimer's medication shows promise in mouse model of neurodegenerative disease

December 19, 2016

Memory loss and other cognitive symptoms of Alzheimer's disease are attributed, in part, to the degeneration of acetylcholine-producing neurons. Acetylcholinesterase inhibitors are a common treatment for patients with Alzheimer's; however, in spite of their clinical benefits, these non-selective medications are also associated with numerous adverse effects. It has been hypothesized that more selective targeting of acetylcholine signaling may reduce the side effects associated with current Alzheimer's medications, but it's not known whether improving selectivity could decrease the treatment's efficacy.

This month in the JCI, work led by Andrew Tobin at the University of Leicester tested two drugs that specifically target the M1 muscarinic acetylcholine receptor in a of neurodegeneration and discovered that the treatments had promising effects.

The mouse model showed many hallmarks of human Alzheimer's disease, including and progressive hippocampal neuron degeneration.

Treatment with the M1-selective medications reversed memory deficits and profoundly extended the lifespan of the diseased mice. These findings support the concept that more specific drugs can be effective in treating the of neurodegenerative disease.

Future work is needed to determine whether these potential medications are effective in humans, and whether the improved targeting actually leads to fewer side effects.

Explore further: Alzheimer's advance: Early stage study in mice show new drugs restore memory loss and prolong life

More information: Sophie J. Bradley et al, M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss, Journal of Clinical Investigation (2016). DOI: 10.1172/JCI87526

Related Stories

How drugs can help your brain encode memories

January 14, 2016

Medical researchers at the University of Bristol have uncovered a fundamental mechanism that explains the interaction between brain state and the neural triggers responsible for learning. The discoveries, made by researchers ...

Memory loss not enough to diagnose Alzheimer's

September 13, 2016

Relying on clinical symptoms of memory loss to diagnose Alzheimer's disease may miss other forms of dementia caused by Alzheimer's that don't initially affect memory, reports a new Northwestern Medicine study.

Recommended for you

Pot may restrict blood flow to brain: study

December 30, 2016

(HealthDay)—Marijuana appears to hamper blood flow to the brain, which theoretically could affect your memory and ability to reason, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.